Sirtuin 5 promotes antiviral response by demalonylating DDX3

被引：0
|
作者：
Han, C. [1 ,2 ]
Li, T. [1 ,2 ]
Qin, K. [1 ,2 ]
Li, N. [1 ,2 ]
Cao, X. [1 ,2 ,3 ,4 ,5 ]
机构：
[1] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China
[2] Second Mil Med Univ, Inst Immunol, Shanghai, Peoples R China
[3] Chinese Acad Med Sci, Inst Basic Med Sci, Peking Union Med Coll, Dept Immunol, Beijing, Peoples R China
[4] Chinese Acad Med Sci, Inst Basic Med Sci, Peking Union Med Coll, Ctr Immunotherapy, Beijing, Peoples R China
[5] Nankai Univ, Coll Life Sci, Tianjin, Peoples R China
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2019年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
O379
引用
收藏
页码：46 / 47
页数：2
相关论文
共 50 条
  • [21] Prokaryotic Expression and Affinity Purification of DDX3 Protein
    Huang, Lan
    Liang, Yue
    Hou, Huijin
    Tang, Min
    Liu, Xinpeng
    Ma, Yan-ni
    Liang, Shufang
    PROTEIN AND PEPTIDE LETTERS, 2024, 31 (03): : 236 - 246
  • [22] The translational landscape as regulated by the RNA helicase DDX3
    Park, Joon Tae
    Oh, Sekyung
    BMB REPORTS, 2022, 55 (03) : 125 - 135
  • [23] Cytoplasmic DDX3 as prognosticator in male breast cancer
    van der Pol, Carmen C.
    Moelans, Cathy B.
    Manson, Quirine F.
    Batenburg, Marilot C. T.
    van der Wall, Elsken
    Rinkes, Inne Borel
    Verkooijen, Lenny
    Raman, Venu
    van Diest, Paul J.
    VIRCHOWS ARCHIV, 2021, 479 (04) : 647 - 655
  • [24] Diosgenin increased DDX3 expression in hepatocellular carcinoma
    Yu, Hong
    Liu, Yuanni
    Niu, Chuanzhen
    Cheng, Yu
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2018, 10 (11): : 3590 - 3599
  • [25] Cytoplasmic DDX3 as prognosticator in male breast cancer
    Carmen C. van der Pol
    Cathy B. Moelans
    Quirine F. Manson
    Marilot C. T. Batenburg
    Elsken van der Wall
    Inne Borel Rinkes
    Lenny Verkooijen
    Venu Raman
    Paul J. van Diest
    Virchows Archiv, 2021, 479 : 647 - 655
  • [26] Rottlerin upregulates DDX3 expression in hepatocellular carcinoma
    Wang, Zhong
    Shen, Gen-hai
    Xie, Jia-ming
    Li, Bin
    Gao, Quan-gen
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 495 (01) : 1503 - 1509
  • [27] Oncogenic role of DDX3 in breast cancer biogenesis
    Botlagunta, M.
    Vesuna, F.
    Mironchik, Y.
    Raman, A.
    Lisok, A.
    Winnard, P., Jr.
    Mukadam, S.
    Van Diest, P.
    Chen, J. H.
    Farabaugh, P.
    Patel, A. H.
    Raman, V.
    ONCOGENE, 2008, 27 (28) : 3912 - 3922
  • [28] Design and synthesis of DDX3 inhibitors as anticancer agent
    Kondaskar, Atul N.
    Kondaskar, Shilpi
    Hosmane, Ramachandra
    Fishbein, James
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [29] Role of DDX3 in the pathogenesis of inflammatory bowel disease
    Tantravedi, Saritha
    Vesuna, Farhad
    Winnard, Paul T., Jr.
    Van Voss, Marise R. Heerma
    Van Diest, Paul J.
    Raman, Venu
    ONCOTARGET, 2017, 8 (70) : 115280 - 115289
  • [30] Targeting DDX3 in medulloblastoma by RK-33
    Tantravedi, Saritha
    Vesuna, Farhad
    Martin, Allison
    Lim, Michael
    Eberhart, Charles G. Eberhart G.
    van Diest, Paul J.
    Raman, Venu
    CANCER RESEARCH, 2018, 78 (13)
12345